openPR Logo
Press release

Insomnia Treatment Market Expected to Grow at 5.2% CAGR from 2024 to 2034

04-25-2024 10:11 PM CET | Health & Medicine

Press release from: Fact.MR

Insomnia Treatment Market Expected to Grow at 5.2% CAGR from 2024

The global insomnia treatment market (不眠症治療市場) is projected to reach a value of US$ 6,886.1 million by 2024 and is expected to grow at a CAGR of 5.2% from 2024 to 2034, reaching US$ 11,385.5 million in 2034. A key driver of this growth is the increasing awareness and understanding of insomnia among patients and healthcare professionals. Insomnia is a prevalent sleep disorder affecting millions worldwide, driving the demand for effective treatments and creating a diverse market for insomnia treatment products and therapies aimed at enhancing sleep quality and duration.

Get Free Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=9613

Market Dynamics

Several factors contribute to the growth of the insomnia treatment market. These include the rising prevalence of insomnia, increasing awareness about the disorder and its consequences, and the growing adoption of sedentary lifestyles leading to sleep disturbances. Additionally, the availability of a wide range of treatment options, including medications, cognitive behavioral therapy, and alternative therapies, further fuels market growth.

On the other hand, factors such as side effects associated with medications, lack of access to healthcare facilities, and the high cost of some treatments can hinder market growth. However, advancements in technology, such as wearable sleep trackers and telemedicine, are expected to create new opportunities in the market.

Market Future Outlook

The insomnia treatment market (불면증 치료 시장) is expected to witness significant growth in the coming years. This growth can be attributed to the increasing prevalence of insomnia, growing geriatric population, and rising awareness about the importance of sleep in maintaining overall health. Moreover, the market is likely to benefit from ongoing research and development activities aimed at introducing innovative treatment options with improved efficacy and fewer side effects.

Market Insights

The insomnia treatment market is segmented based on treatment type, which includes medications, cognitive behavioral therapy, and others. Among these, medications are the most commonly used treatment option, accounting for a significant share of the market. However, cognitive behavioral therapy is gaining traction due to its effectiveness in treating insomnia without the side effects associated with medications.

Geographically, North America dominates the insomnia treatment market, followed by Europe. This can be attributed to the high prevalence of insomnia in these regions, coupled with the presence of well-established healthcare infrastructure. However, the Asia-Pacific region is expected to witness the fastest growth during the forecast period, driven by factors such as the increasing awareness about sleep disorders and the growing demand for effective treatment options.

Key Players

Paratek Pharmaceuticals, Inc.
Vanda Pharmaceuticals Inc.
Sanofi S.A
Merck & Co., Inc.
Sumitomo Dainippon Pharma Co., Ltd.
Teva Pharmaceutical Industries Limited
Viatris Inc.
Takeda Pharmaceutical Company Limited
Pfizer Inc.

Competitive Landscape

Key players in the insomnia treatment industry include pharmaceutical companies as well as startups specializing in alternative remedies and supplements like melatonin and valerian root. As the prevalence of insomnia and related conditions continues to rise, competition in the market is expected to increase.

In 2021, HoneyNaps announced its plans to launch a digital therapy business focused on treating insomnia. The platform includes SOMNUM, an AI-based program for diagnosing sleep problems, My SOMNUM, a non-contact sleep analysis and coaching solution, and SOMNUM Medella, a digital treatment for insomnia.

Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=9613

Segmentation of Insomnia Treatment Market (Markt für die Behandlung von Schlaflosigkeit) Research

By Drug Type:

OTC Drugs

Prescription Drugs

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

eCommerce

Drug Stores & Hypermarkets

By Region:

North America

Europe

Latin America

East Asia

South Asia & Oceania

Middle East & Africa

Contact:

US Sales Office

11140 Rockville Pike

Suite 400 Rockville, MD 20852

United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)

Sales Team: sales@factmr.com

About Fact.MR :

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Insomnia Treatment Market Expected to Grow at 5.2% CAGR from 2024 to 2034 here

News-ID: 3476907 • Views:

More Releases from Fact.MR

Tahini Market Is Estimated To Reach US$ 3.69 Billion By 2033: Fact.MR Report
Tahini Market Is Estimated To Reach US$ 3.69 Billion By 2033: Fact.MR Report
Based on the most recent industry analysis from Fact.MR, the global tahini market reached a valuation of US$ 2.04 billion in 2023 and is anticipated to climb to US$ 3.69 billion by 2033. Projections indicate that tahini sales worldwide are expected to grow at a compound annual growth rate (CAGR) of 6.1% from 2023 to 2033. The Tahini Industry sales study offers a comprehensive analysis on diverse features including production capacities,
Chickpea Market is anticipated to reach US$ 20.12 billion by 2033: Fact.MR Report
Chickpea Market is anticipated to reach US$ 20.12 billion by 2033: Fact.MR Repor …
As of now, the global chickpeas market holds a valuation of US$ 11.45 billion, with projections indicating a significant growth trajectory. By the year 2033, experts forecast this market to soar to a substantial size of US$ 20.12 billion. This growth is underpinned by a forecasted compound annual growth rate (CAGR) of 5.8% in worldwide chickpea consumption by value over the coming decade. Consequently, this expansion is expected to yield
Smart Ports Market Surges Past Us$ 16 Billion Mark by 2033, Fueled by 20.4% CAGR
Smart Ports Market Surges Past Us$ 16 Billion Mark by 2033, Fueled by 20.4% CAGR
Global demand for smart ports market is projected to grow at an impressive CAGR of 20.4% from 2023 to 2033. Presently valued at $2.5 billion, the global smart ports market is expected to soar to $16 billion by the end of 2033. Over the past few decades, ports worldwide have undergone significant structural and functional transformations. Today, a surge of technological innovation and integration is driving industries and enterprises toward digital
Prebiotic Fiber Market Is Set To Reach US$ 19.94 Billion By 2033: Fact.MR Report
Prebiotic Fiber Market Is Set To Reach US$ 19.94 Billion By 2033: Fact.MR Report
The worldwide prebiotic fiber market, which was valued at US$ 7.08 billion in 2023, is anticipated to experience robust growth, with a noteworthy compound annual growth rate (CAGR) of 10.9%. By the conclusion of 2033, it is forecasted to attain a substantial market size of US$ 19.94 billion. The Prebiotic Fiber Industry sales study offers a comprehensive analysis on diverse features including production capacities, Prebiotic Fiber demand, product developments, sales revenue

All 5 Releases


More Releases for Pharma

Antiemetics Market Size 2022 Analysis by Top Key Players| Acacia Pharma Group Pl …
Antiemetics Market research added by the Absolute Markets Insights, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry. In addition, the study explicitly highlights the competitive status of key players within the projection timeline while focusing on their portfolio and regional expansion endeavors. Access the PDF sample of the report@
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the
Indometacin Market Top Key Manufacturers Aidarex, Ratiopharm, Merck, Xinhua Phar …
The Global Indometacin Market is a nonsteroidal anti-inflammatory drug commonly used as a prescription medication to reduce fever, pain, stiffness, and swelling from inflammation. The demand for nonsteroidal anti-inflammatory drug has been increasing owing to the emergence of anti-inflammatory biologics that are more targeted. However, such as side effects of anti-inflammatory drugs and patent expiry issues may hamper the market growth in the review period. For More Info, Get Sample Report
Hydroxycarbamide Market Study Report 2019| Taj Pharma, Beijing Jialin Pharma, Qi …
Los Angeles, United State, June 11, 2019, - The global Hydroxycarbamide market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global Hydroxycarbamide
TIGLUTIK Market 2019: Top Players are Sanofi, Mylan Pharma, Apotex, Glemark Gene …
TIGLUTIK Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry. Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13709986 Global TIGLUTIK market 2019 research provides a basic overview of the industry including definitions, classifications, applications